Analyst Ratings for [CRON] Cronos Group Inc.

11/2/22	Initiated	Mkt Perform	X
CRON Cronos Group Bernstein
$3
7/28/22	Upgrades	Hold Buy	X
CRON Cronos Group Canaccord Genuity
5/11/22	Upgrades	Neutral Sec Outperform	X
CRON Cronos Group CIBC
3/22/22	Upgrades	Underweight Eq Weight	X
CRON Cronos Group Barclays
1/27/22	Upgrades	Underperform Hold	X
CRON Cronos Group Jefferies
$5.54 $3.24
11/18/21	Resumed	Underperform	X
CRON Cronos Group BofA Securities
$5
4/28/21	Resumed	Underperform	X
CRON Cronos Group BofA Securities
$7.50
2/22/21	Downgrades	Sec Outperform Neutral	X
CRON Cronos Group CIBC
$8 $12.50
8/13/19	Initiated	Overweight	X
CRON Cronos Group Piper Jaffray
8/9/19	Upgrades	Sell Hold	X
CRON Cronos Group Canaccord Genuity
6/28/19	Initiated	Equal Weight	X
CRON Cronos Group Consumer Edge Research
6/6/19	Initiated	Hold	X
CRON Cronos Group Stifel
6/5/19	Upgrades	Underperform Buy	X
CRON Cronos Group BofA/Merrill
4/17/19	Initiated	Underperform	X
CRON Cronos Group BofA/Merrill
3/27/19	Downgrades	Hold Sell	X
CRON Cronos Group Canaccord Genuity
2/25/19	Initiated	Underperform	X
CRON Cronos Group Jefferies
1/18/19	Initiated	Sector Outperform	X
CRON Cronos Group CIBC

CRON Cronos Group Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations (MMPR). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.